Perspective Therapeutics SG&A Expense (TTM) Insights

Perspective Therapeutics Inc (CATX)

1.38 +0.06 (+4.55%) USD | NYAM | May 31, 16:00

1.395 +0.02 (+1.09%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 1999. Upgrade now.

Date	Value
March 31, 2024	19.11M
December 31, 2023	19.89M
September 30, 2023	22.11M
June 30, 2023	18.80M
March 31, 2023	15.08M
September 30, 2022	10.74M
June 30, 2022	9.425M
March 31, 2022	9.16M
December 31, 2021	8.656M
September 30, 2021	8.084M
June 30, 2021	7.131M
March 31, 2021	7.098M
December 31, 2020	7.294M
September 30, 2020	7.283M
June 30, 2020	7.547M
March 31, 2020	7.291M
December 31, 2019	7.075M
September 30, 2019	7.141M
June 30, 2019	6.851M
March 31, 2019	7.404M
December 31, 2018	7.135M
September 30, 2018	6.991M
June 30, 2018	6.824M
March 31, 2018	6.637M
December 31, 2017	6.517M

Date	Value
September 30, 2017	6.234M
June 30, 2017	6.23M
March 31, 2017	5.701M
December 31, 2016	5.557M
September 30, 2016	5.56M
June 30, 2016	5.139M
March 31, 2016	4.773M
December 31, 2015	4.527M
September 30, 2015	3.989M
June 30, 2015	3.889M
March 31, 2015	3.741M
December 31, 2014	3.624M
September 30, 2014	3.622M
June 30, 2014	3.703M
March 31, 2014	3.649M
December 31, 2013	3.675M
September 30, 2013	3.691M
June 30, 2013	3.642M
March 31, 2013	3.658M
December 31, 2012	3.619M
September 30, 2012	3.564M
June 30, 2012	3.570M
March 31, 2012	3.529M
December 31, 2011	3.557M
September 30, 2011	3.653M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

6.851M

Minimum

Jun 2019

22.11M

Maximum

Sep 2023

10.83M

Average

8.084M

Median

Sep 2021

SG&A Expense (TTM) Benchmarks